Bilal Omer

Bilal Omer, M.D., is an Associate Professor in the Department of Pediatrics at Baylor College of Medicine, with a specific focus on Hematology-Oncology and Cell & Gene Therapy. He also serves as a Member of the Dan L Duncan Comprehensive Cancer Center. His clinical and research activities are centered at Texas Children's Hospital in Houston, Texas.

Dr. Omer's education includes a Residency and Internship in Medicine and Pediatrics at Yale-New Haven Hospital, followed by a Fellowship in Pediatric Hematology and Oncology at Baylor College of Medicine. He holds certifications from the American Board of Pediatrics and the American Board of Internal Medicine, with subspecialty certification in Pediatric Hematology/Oncology.

His research interests span cellular immunotherapies, including CAR T-cell engineering for solid tumors, hematopoietic stem cell transplantation (HSCT), and management of viral infections post-transplant. He has pioneered work on enhancing T-cell persistence via IL-7 signaling modulation and developing off-the-shelf multivirus-specific T-cell therapies for high-risk infections in immunocompromised patients.

Dr. Omer's clinical trials and translational research emphasize improving outcomes for pediatric patients with leukemia, neuroblastoma, and genetic disorders like sickle cell disease. His work integrates innovative gene therapy approaches with precision medicine strategies to address unmet clinical needs in pediatric oncology and hematology.

His contributions include over 30 peer-reviewed publications, with a focus on optimizing adoptive T-cell therapies, reducing transplant-related complications, and advancing CAR-T cell efficacy against both hematologic malignancies and solid tumors.